Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2014

Open Access 01-12-2014 | Research article

Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis

Authors: Ilham Bouaddi, Samira Rostom, Dalal El Badri, Asmae Hassani, Bouchra Chkirate, Redoine Abouqal, Bouchra Amine, Najia Hajjaj-Hassouni

Published in: BMC Musculoskeletal Disorders | Issue 1/2014

Login to get access

Abstract

Background

In addition to its important metabolic activities, vitamin D also contributes to the regulation of the immune system. The aim of this study was to assess the relationship between hypovitaminosis D and disease activity in Moroccan children with juvenile idiopathic arthritis (JIA).

Methods

In this cross-sectional study, forty children with JIA were included, all having been diagnosed according to the classification criteria of International League of Associations for Rheumatology (ILAR). The children underwent anthropometric assessment and clinical evaluation. Disease activity was measured using the Disease Activity Score in 28 joints (DAS28) for polyarticular and oligoarticular JIA and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) for enthesitis-related arthritis. Serum 25-hydroxyvitamin [25(OH)D] D2 and D3 were measured using radioimmunoassay (RIA). Hypovitaminosis D was defined as serum 25(OH)D <30 ng/ml.

Results

The average age of participants was 11 years ± 4.23. Hypovitaminosis D was observed in 75% of patients. In univariate analyses, 25(OH)D levels were negatively associated with DAS28 for polyarticular and oligoarticular JIA. No significant relationship was found between 25(OH)D levels and BASDAI for juvenile spondylarthropathy. In multivariate linear regression analysis, no association persisted between 25(OH)D levels and DAS28.

Conclusions

Our study suggested that serum levels of vitamin D were low in Moroccan children with JIA disease. Future studies with a larger population are needed to confirm our results.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oren Y, Shapira Y, Agmon-Levin N, Kivity S, Zafrir Y, Altman A, Lerner A, Shoenfeld Y: Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr Med Assoc J. 2010, 12: 751-756.PubMed Oren Y, Shapira Y, Agmon-Levin N, Kivity S, Zafrir Y, Altman A, Lerner A, Shoenfeld Y: Vitamin D insufficiency in a sunny environment: a demographic and seasonal analysis. Isr Med Assoc J. 2010, 12: 751-756.PubMed
2.
3.
go back to reference Ginde AA, Liu MC, Camargo CA: Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009, 169 (6): 626-632. 10.1001/archinternmed.2008.604.CrossRefPubMedPubMedCentral Ginde AA, Liu MC, Camargo CA: Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009, 169 (6): 626-632. 10.1001/archinternmed.2008.604.CrossRefPubMedPubMedCentral
4.
go back to reference Mishal AA: Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int. 2001, 12 (11): 931-935. 10.1007/s001980170021.CrossRefPubMed Mishal AA: Effects of different dress styles on vitamin D levels in healthy young Jordanian women. Osteoporos Int. 2001, 12 (11): 931-935. 10.1007/s001980170021.CrossRefPubMed
5.
go back to reference Pelajo CF, Lopez-Benitez JM, Miller LC: Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev. 2010, 9 (7): 507-510. 10.1016/j.autrev.2010.02.011.CrossRefPubMed Pelajo CF, Lopez-Benitez JM, Miller LC: Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev. 2010, 9 (7): 507-510. 10.1016/j.autrev.2010.02.011.CrossRefPubMed
6.
go back to reference Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E: Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008, 10 (5): R123-10.1186/ar2533.CrossRefPubMedPubMedCentral Zold E, Szodoray P, Gaal J, Kappelmayer J, Csathy L, Gyimesi E, Zeher M, Szegedi G, Bodolay E: Vitamin D deficiency in undifferentiated connective tissue disease. Arthritis Res Ther. 2008, 10 (5): R123-10.1186/ar2533.CrossRefPubMedPubMedCentral
7.
go back to reference Crai SM, Yu F, Curtis JR, Alarcón GS, Conn DL, Jonas B, Callahan LF, Smith EA, Moreland LW, Bridges SL, Mikuls TR: Vitamin D status and its associations with disease activity and severity in African Americans with recent onset rheumatoid arthritis. J Rheumatol. 2010, 37 (2): 275-281. 10.3899/jrheum.090705.CrossRef Crai SM, Yu F, Curtis JR, Alarcón GS, Conn DL, Jonas B, Callahan LF, Smith EA, Moreland LW, Bridges SL, Mikuls TR: Vitamin D status and its associations with disease activity and severity in African Americans with recent onset rheumatoid arthritis. J Rheumatol. 2010, 37 (2): 275-281. 10.3899/jrheum.090705.CrossRef
8.
go back to reference Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D: Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007, 56 (7): 2143-2149. 10.1002/art.22722.CrossRefPubMed Patel S, Farragher T, Berry J, Bunn D, Silman A, Symmons D: Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum. 2007, 56 (7): 2143-2149. 10.1002/art.22722.CrossRefPubMed
9.
go back to reference Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B: Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol. 2006, 24 (6): 702-704.PubMed Cutolo M, Otsa K, Laas K, Yprus M, Lehtme R, Secchi ME, Sulli A, Paolino S, Seriolo B: Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin Exp Rheumatol. 2006, 24 (6): 702-704.PubMed
10.
go back to reference Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL: Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int. 2005, 16 (12): 1999-2004. 10.1007/s00198-005-1990-5.CrossRefPubMed Lange U, Teichmann J, Strunk J, Muller-Ladner U, Schmidt KL: Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int. 2005, 16 (12): 1999-2004. 10.1007/s00198-005-1990-5.CrossRefPubMed
11.
go back to reference Pelajo CF, Lopez-Benitez JM, Miller LC: 25-hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol. 2011, 38 (9): 2000-2004. 10.3899/jrheum.110123.CrossRefPubMed Pelajo CF, Lopez-Benitez JM, Miller LC: 25-hydroxyvitamin D levels and vitamin D deficiency in children with rheumatologic disorders and controls. J Rheumatol. 2011, 38 (9): 2000-2004. 10.3899/jrheum.110123.CrossRefPubMed
12.
go back to reference Amine B, Ibn Yacoub Y, Rostom S, Hajjaj-Hassouni N: Prevalence of overweight among Moroccan children and adolescents with juvenile idiopathic arthritis. Joint Bone Spine. 2011, 78 (6): 584-586. 10.1016/j.jbspin.2011.02.001.CrossRefPubMed Amine B, Ibn Yacoub Y, Rostom S, Hajjaj-Hassouni N: Prevalence of overweight among Moroccan children and adolescents with juvenile idiopathic arthritis. Joint Bone Spine. 2011, 78 (6): 584-586. 10.1016/j.jbspin.2011.02.001.CrossRefPubMed
13.
go back to reference Weiss JE, Ilowite NT: Juvenile idiopathic arthritis. Pediatr Clin North Am. 2005, 52 (2): 413-442. 10.1016/j.pcl.2005.01.007.CrossRefPubMed Weiss JE, Ilowite NT: Juvenile idiopathic arthritis. Pediatr Clin North Am. 2005, 52 (2): 413-442. 10.1016/j.pcl.2005.01.007.CrossRefPubMed
14.
go back to reference Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004, 31 (2): 390-392.PubMed Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004, 31 (2): 390-392.PubMed
15.
go back to reference Rostom S, Amine B, Bensabbah R, Chkirat B, Abouqal R, Hajjaj-Hassouni N: Psychometric properties evaluation of the childhood health assessment questionnaire (CHAQ) in Moroccan juvenile idiopathic arthritis. Rheumatol Int. 2010, 30 (7): 879-885. 10.1007/s00296-009-1069-2.CrossRefPubMed Rostom S, Amine B, Bensabbah R, Chkirat B, Abouqal R, Hajjaj-Hassouni N: Psychometric properties evaluation of the childhood health assessment questionnaire (CHAQ) in Moroccan juvenile idiopathic arthritis. Rheumatol Int. 2010, 30 (7): 879-885. 10.1007/s00296-009-1069-2.CrossRefPubMed
16.
go back to reference Ringold S, Chon Y, Singer NG: Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis. Arthritis Rheum. 2009, 60 (12): 3776-3783. 10.1002/art.24983.CrossRefPubMed Ringold S, Chon Y, Singer NG: Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis. Arthritis Rheum. 2009, 60 (12): 3776-3783. 10.1002/art.24983.CrossRefPubMed
17.
go back to reference Lurati A, Pontikaki I, Teruzzi B, Desiati F, Gerloni V, Gattinara M, Cimaz R, Fantini F: A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents. Arthritis Rheum. 2006, 54 (5): 1602-1607. 10.1002/art.21784.CrossRefPubMed Lurati A, Pontikaki I, Teruzzi B, Desiati F, Gerloni V, Gattinara M, Cimaz R, Fantini F: A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents. Arthritis Rheum. 2006, 54 (5): 1602-1607. 10.1002/art.21784.CrossRefPubMed
18.
go back to reference Viswanath V, Myles A, Dayal R, Aggarwal A: Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. J Rheumatol. 2011, 38 (11): 2482-2487. 10.3899/jrheum.110352.CrossRefPubMed Viswanath V, Myles A, Dayal R, Aggarwal A: Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis. J Rheumatol. 2011, 38 (11): 2482-2487. 10.3899/jrheum.110352.CrossRefPubMed
19.
go back to reference Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004, 80 (6 Suppl): 1678-88S. Holick MF: Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004, 80 (6 Suppl): 1678-88S.
20.
go back to reference Pelajo CF, Lopez-Benitez JM, Kent DM, Price LL, Miller LC, Dawson-Hughes B: 25-25. hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?. Rheumatol Int. 2012, 32 (12): 3923-3929. 10.1007/s00296-011-2287-y.CrossRefPubMed Pelajo CF, Lopez-Benitez JM, Kent DM, Price LL, Miller LC, Dawson-Hughes B: 25-25. hydroxyvitamin D levels and juvenile idiopathic arthritis: Is there an association with disease activity?. Rheumatol Int. 2012, 32 (12): 3923-3929. 10.1007/s00296-011-2287-y.CrossRefPubMed
21.
go back to reference Lips P: Vitamin D physiology. Prog Biophys Mol Biol. 2006, 92 (1): 4-8. 10.1016/j.pbiomolbio.2006.02.016.CrossRefPubMed Lips P: Vitamin D physiology. Prog Biophys Mol Biol. 2006, 92 (1): 4-8. 10.1016/j.pbiomolbio.2006.02.016.CrossRefPubMed
22.
go back to reference Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B: Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007, 7 (1): 59-64. 10.1016/j.autrev.2007.07.001.CrossRefPubMed Cutolo M, Otsa K, Uprus M, Paolino S, Seriolo B: Vitamin D in rheumatoid arthritis. Autoimmun Rev. 2007, 7 (1): 59-64. 10.1016/j.autrev.2007.07.001.CrossRefPubMed
23.
go back to reference Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A: Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm. 2011, 86: 327-351.CrossRefPubMed Cutolo M, Plebani M, Shoenfeld Y, Adorini L, Tincani A: Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam Horm. 2011, 86: 327-351.CrossRefPubMed
24.
go back to reference Smolders J, Peelen E, ThewissenM MP, Tervaert JW, Hupperts R, Damoiseaux J: The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009, 8 (7): 621-626. 10.1016/j.autrev.2009.02.009.CrossRefPubMed Smolders J, Peelen E, ThewissenM MP, Tervaert JW, Hupperts R, Damoiseaux J: The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009, 8 (7): 621-626. 10.1016/j.autrev.2009.02.009.CrossRefPubMed
25.
go back to reference Zold E, Barta Z, Bodolay E: Vitamin D deficiency and connective tissue disease. Vitam Horm. 2011, 86: 261-286.CrossRefPubMed Zold E, Barta Z, Bodolay E: Vitamin D deficiency and connective tissue disease. Vitam Horm. 2011, 86: 261-286.CrossRefPubMed
26.
go back to reference Als OS, Riis B, Christiansen C: Serum concentration of vitamin D metabolites in rheumatoid arthritis. Clin Rheumatol. 1987, 6 (2): 238-243. 10.1007/BF02201030.CrossRefPubMed Als OS, Riis B, Christiansen C: Serum concentration of vitamin D metabolites in rheumatoid arthritis. Clin Rheumatol. 1987, 6 (2): 238-243. 10.1007/BF02201030.CrossRefPubMed
27.
go back to reference Turhanoğlu AD, Güler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C: The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. 2011, 31 (7): 911-914. 10.1007/s00296-010-1393-6.CrossRefPubMed Turhanoğlu AD, Güler H, Yönden Z, Aslan F, Mansuroglu A, Ozer C: The relationship between vitamin D and disease activity and functional health status in rheumatoid arthritis. Rheumatol Int. 2011, 31 (7): 911-914. 10.1007/s00296-010-1393-6.CrossRefPubMed
28.
go back to reference Bird HA, Peacock M, Storer JH, Wright V: Comparison of serum 25-OH vitamin D concentrations in rheumatoid arthritis and osteoarthrosis. Br Med J. 1980, 280 (6229): 1416-10.1136/bmj.280.6229.1416.CrossRefPubMedPubMedCentral Bird HA, Peacock M, Storer JH, Wright V: Comparison of serum 25-OH vitamin D concentrations in rheumatoid arthritis and osteoarthrosis. Br Med J. 1980, 280 (6229): 1416-10.1136/bmj.280.6229.1416.CrossRefPubMedPubMedCentral
29.
go back to reference Becker A, Fischer R, Schneider M: Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol. 2001, 60 (5): 352-358. 10.1007/s003930170035. GermanCrossRefPubMed Becker A, Fischer R, Schneider M: Bone density and 25-OH vitamin D serum level in patients with systemic lupus erythematosus. Z Rheumatol. 2001, 60 (5): 352-358. 10.1007/s003930170035. GermanCrossRefPubMed
30.
go back to reference Carrasco R, Lovell DJ, Giannini EH, Henderson CJ, Huang B, Kramer S, Ranz J, Heubi J, Glass D: Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis. Arthritis Rheum. 2008, 58 (12): 3932-3940. 10.1002/art.24041.CrossRefPubMedPubMedCentral Carrasco R, Lovell DJ, Giannini EH, Henderson CJ, Huang B, Kramer S, Ranz J, Heubi J, Glass D: Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis. Arthritis Rheum. 2008, 58 (12): 3932-3940. 10.1002/art.24041.CrossRefPubMedPubMedCentral
31.
go back to reference Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y: Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci. 2007, 1109: 385-400. 10.1196/annals.1398.044.CrossRefPubMed Orbach H, Zandman-Goddard G, Amital H, Barak V, Szekanecz Z, Szucs G, Danko K, Nagy E, Csepany T, Carvalho JF, Doria A, Shoenfeld Y: Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann NY Acad Sci. 2007, 1109: 385-400. 10.1196/annals.1398.044.CrossRefPubMed
Metadata
Title
Vitamin D concentrations and disease activity in Moroccan children with juvenile idiopathic arthritis
Authors
Ilham Bouaddi
Samira Rostom
Dalal El Badri
Asmae Hassani
Bouchra Chkirate
Redoine Abouqal
Bouchra Amine
Najia Hajjaj-Hassouni
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2014
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/1471-2474-15-115

Other articles of this Issue 1/2014

BMC Musculoskeletal Disorders 1/2014 Go to the issue